FGF21 and metabolic dysfunction-associated steatotic liver disease: Whether this improvement is sustained with long-term aerobic exercise training in patients with established NAFLD/NASH is unknown, as the only study performed to date in patients with NAFLD that demonstrated a reduction in serum FGF21 utilized a 12-week resistance training program and not aerobic exercise [22].